Table 1.
Patients’ characteristics
| Characteristics | Group | All (n = 39) |
p value | |
|---|---|---|---|---|
| IND (n = 11) |
CHD (n = 28) |
|||
| Male sex | 2 (18.2) | 18 (64.3) | 20 (51.3) | 0.014* |
| Age (years) | 48.3 ± 12.2 | 57.4 ± 12.5 | 54.8 ± 12.9 | 0.045† |
| Mean NYHA functional class | 1 ± 0 | 2.2 ± 0.8 | 1.8 ± 0.9 | < 0.001‡ |
| NYHA functional class > 1 | 0 (0) | 21 (75.0) | 28 (71.8) | < 0.001* |
| LVEF (%) | 57.9 ± 4.7 | 33.7 ± 16.5 | 40.5 ± 17.9 | < 0.001 ‡ |
| EDV (ml/m2) | 64.5 ± 11.8 | 121.2 ± 62.2 | 105.2 ± 58.7 | 0.002 ‡ |
| ESV (ml/m2) | 26.7 ± 6.5 | 82.8 ± 55.5 | 67.0 ± 53.4 | < 0.001 ‡ |
| LV mass (g/m2) | 46.7 ± 21.7 | 79.5 ± 34.6 | 70.2 ± 34.6 | 0.006 ‡ |
| RVEF (%) | 41.5 ± 13.8 | 35.2 ± 12.5 | 37.0 ± 13.0 | NS |
Data are expressed as mean ± SD or number (%).
*
Fisher’s exact test;
†
Student’s t test;
‡
Kruskal-Wallis test. IND: indeterminate; CHD: Chagas heart disease; NYHA: New York Heart Association; LVEF: left ventricular ejection fraction; EDV: end diastolic volume; ESV: end-systolic volume; RVEF: right ventricular ejection fraction; NS: not significant.